A combination of pinitol and creatine to enhance uptake and retention of creatine

Details for Australian Patent Application No. 2001253598 (hide)

Owner AdvantRx Corporation

Inventors Dykstra, John C.

Agent Spruson & Ferguson

Pub. Number AU-B-2001253598

PCT Pub. Number WO01/80853

Priority 60198390 19.04.00 US

Filing date 16 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 15 December 2005

International Classifications

A61K 31/198 (2006.01)

A61K 31/047 (2006.01)

Event Publications

29 July 2004 Assignment before Grant

  Humanetics Corporation The application has been assigned to AdvantRx Corporation

15 December 2005 Application Accepted

  Published as AU-B-2001253598

27 April 2006 Standard Patent Sealed

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253599-Systems and methods for ambulatory monitoring of physiological signs

2001253597-Treatment of neurodegenerative disease